ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • Clin Pharmacol Biopharm 2023, Vol 12(6): 343
  • DOI: 10.4172/2167-065X.1000343

Advancement in Drug Delivery is the Development of Nanotechnology Based System

Zhen Huang*
Department of Pharmaceutical Sciences Ulster University, Ireland
*Corresponding Author : Zhen Huang, Department of Pharmaceutical Sciences Ulster University, Ireland, Email: zhen.huang@uth.tmc.edu

Received Date: Jun 01, 2023 / Published Date: Jun 28, 2023

Abstract

Advances in drug delivery systems have revolutionized the field of healthcare by enhancing therapeutic efficacy and improving patient compliance. Traditional drug delivery methods often faced challenges such as poor bioavailability, low solubility, rapid clearance from the body, and inconsistent drug release profiles. However, recent innovations in drug delivery have overcome these limitations, leading to more efficient and targeted treatments. One major advancement in drug delivery is the development of nanotechnology-based systems. Nanoparticles, liposomes, and micelles are engineered to encapsulate drugs, protecting them from degradation and enabling precise delivery to the desired site of action. These nanocarriers can be designed to release the drug in a controlled manner, prolonging its therapeutic effect and reducing the frequency of administration. Furthermore, their small size allows for enhanced cellular uptake, increasing drug concentration at the target site while minimizing side effects on healthy tissues.

Citation: Huang Z (2023) Advancement in Drug Delivery is the Development of Nanotechnology-Based Systems. Clin Pharmacol Biopharm, 12: 343. Doi: 10.4172/2167-065X.1000343

Copyright: © 2023 Huang Z. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top